ÉñÂí¸£ÀûӰƬ

This presentation is designed to provide information on the emergency use authorization of Paxlovid (nirmatrelvir; ritonavir oral tablets) for the treatment of COVID-19. The following topics will be discussed in detail during the live webinar.

Outline:

•       SARS-CoV-2 Viral Replication Cycle: Proteolysis

•       Nirmatrelvir: Mechanism of Action

•       Co-administration of nirmatrelvir and ritonavir

•       FDA Authorized Use

•       Warnings

•       Dosage and Administration

•       Contraindications

•       Drug Interactions

•       Additional Information

Presented By:           

Rand Sulaiman, PharmD, BCIDP